Monitoring Agency Report for the quarter ended 30th September 2025
GRASIM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Grasim Industries has filed the Monitoring Agency Report from CARE Ratings for Q2 FY26 (quarter ended Sept 30, 2025) on the use of proceeds from its January 2024 Rights Issue of ₹3,999.80 crore. Of the ₹3,977.65 crore earmarked for specific objects, ₹3,970.46 crore has been deployed — ₹2,999.9981 crore toward repayment/prepayment of borrowings and ₹970.46 crore for general corporate purposes. The general corporate purposes spend was mainly ₹967.26 crore for commercial paper repayment and ₹3.20 crore for salaries. The Monitoring Agency confirmed there is no deviation from the stated objects and no material change in means of finance. Only ₹0.4467 crore remains unutilized, held in the Axis Bank monitoring account.
This is a routine compliance filing that confirms disciplined, on-track use of the rights issue proceeds with no deviations, a positive signal for governance. The near-complete deployment toward debt reduction should reassure investors about balance sheet deleveraging.